Bovine viral diarrhea viruses differentially alter the expression of the protein kinases and related proteins affecting the development of infection and anti-viral mechanisms in bovine monocytes

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1784, Issue 9, 2008, Pages 1234-1247

  Pinchuk, George V ^a   Lee, Sang Ryul ^b   Nanduri, Bindu ^b   Honsinger, Kelly L ^a   Stokes, John V ^b   Pinchuk, Lesya M ^b  

^a MISSISSIPPI UNIVERSITY FOR WOMEN   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

2D LC ESI MS2; Anti viral mechanism; BVDV; DDF; Monocyte; MudPIT; Protein kinase; Xcorr

Indexed keywords

BRUTONS TYROSINE KINASE; DIACYGLYCEROL KINASE; INTERFERON; PHOSPHOTRANSFERASE; PROTEIN KINASE; PYRIDOXAL KINASE; RECEPTOR FOR ACTIVATED C KINASE 1; UNCLASSIFIED DRUG; PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; BOVINE DIARRHEA VIRUS; CATTLE DISEASE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CYTOSOLIC FRACTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEOMICS; VIRUS CELL TRANSFORMATION; ANIMAL; CATTLE; CYTOPATHOGENIC EFFECT; ELECTROSPRAY MASS SPECTROMETRY; ENZYMOLOGY; IN VITRO STUDY; ISOLATION AND PURIFICATION; METABOLISM; PATHOGENICITY; VIROLOGY;

BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1;

ANIMALS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; CHROMATOGRAPHY, LIQUID; CYTOPATHOGENIC EFFECT, VIRAL; DIARRHEA VIRUS 1, BOVINE VIRAL; MONOCYTES; PROTEIN KINASES; PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 53149102078     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2008.05.004     Document Type: Article

References (118)

1. M.S. Colett, V. Moenning, M.C. Horzinek, Recent advances in pestivirus research, J. Gen. Virol 70 (1989) 253-266.
2. P.F. Nettleton, G. Entrican, Ruminant pestiviruses, Br. Vet. J 151 (1995) 615-642.
3. R.W. Fulton, J.F. Ridpath, S. Ore, A.W. Confer, J.T. Saliki, L.J. Burge, M.E. Payton, Bovine viral diarrhoea virus (BVDV) subgenotypes in diagnostic laboratory accessions: distribution of BVDV 1a, 1b, and 2a subgenotypes, Vet. Microbiol 111 (2005) 35-40.
4. D.L. Montgomery, Distribution and cellular heterogeneity of bovine viral diarrhea viral antigen expression in the brain of persistently infected calves: a new perspective, Vet. Pathol 44 (2007) 643-654.
5. S.R. Bolin, The pathogenesis of mucosal disease, Vet. Clin. North Am., Food Anim. Pract 11 (1995) 489-500.
6. J.D. Neill, J.F. Ridpath, Gene expression changes in MDBK cells infected with genotype 2 bovine viral diarrhoea virus, Vet. Microbiol 96 (2003) 301-312.
7. S. Bendfeldt, J.F. Ridpath, J.D. Neill, Activation of cell signalling pathways is dependant on the biotype of bovine viral diarrhea viruses type 2, Virus Res 126 (2007) 96-105.
8. N. Tautz, G. Meyers, H.-J. Thiel, Pathogenesis of mucosal disease, a deadly disease of cattle caused by pestivirus, Clin. Diagn. Virol. 10 (1998) 121-127.
9. R. Cattaneo, Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogen's magnet, J. Virol. 78 (2004) 4385-4388.
10. P. Sopp, L.B. Hooper, M.C. Clarke, C.J. Howard, J. Brownlie, Detection of bovine viral diarrhoea virus p80 protein in subpopulations of bovine lekocytes, J. Gen. Virol. 75 (1994) 1189-1194.
11. H. Adler, T.W. Jungi, H. Pfister, M. Strasser, M. Sileghem, E. Peterhans, Cytokine regulation by virus infection: bovine viral diarrhea virus, a flavivirus, down-regulates production of tumor necrosis factor alpha in macrophages in vitro, J. Virol. 70 (1996) 2650-2653.
12. B.L. Boyd, T.M. Lee, E.F. Kruger, L.M. Pinchuk, Cytopathic and non-cytopathic bovine viral diarrhea virus biotypes affect fluid phase uptake and mannose receptor-mediated endocytosis in bovine monocytes, Vet. Immunol. Immunopathol. 102 (2004) 53-65.
13. N. Tautz, H.-J. Thiel, E.J. Dubovi, G. Meyers, Pathogenesis of mucosal disease: a cytopathogenic pestivirus generated by an internal deletion, J. Virol 68 (1994) 3289-3297.
14. E.J. Glew, B.V. Carr, L.S. Brackenbury, J.C. Hope, B. Charleston, C.J. Howard, Differential effect of bovine viral diarrhoea virus on monocytes and dendritic cells, J. Gen. Virol 84 (2003) 1771-1780.
15. O.M. Radostits, I.R. Littlejohns, New concepts in the pathogenesis, diagnosis and control of disease caused by the bovine viral diarrhea virus, Can. Vet. J. 29 (1988) 513-528.
16. H. Bielefelt-Ohmann, The pathogenesis of bovine viral diarrhea virus infection. A window on the pathogenesis, Vet. Clin. North Am., Food Anim. Pract 11 (1995) 447-476.
17. B. Adler, H. Adler, H. Phister, T. Jungi, E. Peterhans, Macrophages infected with cytopathic bovine viral diarrhea virus release a factor(s) capable of priming uninfected macrophages for activation-induced apoptosis, J. Virol 71 (1997) 3255-3258.
18. R. Jordan, L. Wang, T.M. Graczyk, T.M. Block, P.R. Romano, Replication of a cytopathic strain of bovine viral diarrhea virus activates PEFK and induces endoplasmic reticulum stress-mediated apoptosis of MDBK cells, J. Virol 76 (2002) 9588-9599.
19. M. Lambot, E. Hanon, C. Lecomte, C. Hamers, J.-J. Letesson, P.-P. Pastoret, Bovine viral diarrhoea virus induces apoptosis in blood mononuclear cells by a mechanism largely dependent on monocytes, J. Gen. Virol 79 (1998) 1745-1749.
20. M. Schweizer, E. Peterhaus, Oxidative stress in cells infected with bovine viral diarrhoea virus: a crucial step in the induction of apoptosis, J. Gen. Virol 80 (1999) 1147-1155.
21. T. Burmeister, Oncogenic retroviruses in animals and humans, Rev. Med. Virol 11 (2001) 369-380.
22. H. zur Hausen, Viruses in human cancers, Curr. Sci. 81 (2001) 523-527.
23. W.H. Jarrett, P.E. McNeil, T.R. Grimshaw, I.E. Selman, I.M. McIntyre, High incidence area of cattle cancer with a possible interaction between an environmental carcinogen and a papilloma virus, Nature 274 (1978) 215-217.
24. W. Misdrop, Veterinary cancer eidemiology, Vet. Q 18 (1996) 32-36.
25. U. Truyen, M. Lochelt, Relevant oncogenic viruses in veterinary medicine: original pathogens and animal models for human diseases, in: T. Dittmar, K.S. Zaecker, A. Schmidt (Eds.), Infection and Inflammation: Impacts on Oncogenesis, Contrib. Microbiol., 13, Karger, Basel, 2006, pp. 107-117.
26. J.E. Moulton, D.L. Dungworth, Tumors of the lymphoid and hemopoietic tissues, in: J.E. Moulton (Ed.), Tumors in domestic Animals, second ed., University of California Press, 1978, pp. 150-204, Berkeley et al.
27. R. Aebersold, D.R. Goodlett, Mass spectrometry in proteomics, Chem. Rev 101 (2001) 269-295.
28. R. Aebersold, B.F. Cravatt, Proteomics - advances, applications and the challenges that remain, Trends Biotechnol. 20 (2002) S1-S2.
29. H. Zhu, M. Bilgin, M. Snyder, Proteomics, Ann. Rev. Biochem 72 (2003) 783-812.
30. M. Tyers, M. Mann, From genomics to proteomics, Nature 422 (2003) 193-197.
31. A.D.Weston, L. Hood, Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine, J. Proteome Res. 3 (2004) 179-196.
32. E. Petricoin, J. Wulfkuhle, V. Espina, L.A. Liotta, Clinical proteomics: revolutionizing disease detection and patient tailoring therapy, J. Proteome Res 3 (2004) 209-217.
33. F. Vitzthum, F. Behrens, N.L. Anderson, J.H. Shaw, Proteomics: from basic research to diagnostic application. A review of requirements and needs, J. Proteome Res 4 (2005) 1086-1097.
34. P. Kellam, Post-genomic virology: the impact of bioinformatics, microarrays and proteomics on investigating host and pathogen interactions, Rev. Med. Virol. 11 (2001) 313-329.
35. S.-R. Lee, G.T. Pharr, A.M. Cooksey, F.M. McCarthy, B.L. Boyd, L.M. Pinchuk, Differential detergent fractionation for non-electrophoretic bovine peripheral blood monocyte proteomics reveals proteins involved in professional antigen presentation, Dev. Comp. Immunol 30 (2006) 1070-1083.
36. E.F. Kruger, B.L. Boyd, L.M. Pinchuk, Bovine monocytes induce immunoglobulin production in peripheral blood B lymphocytes, Dev. Comp. Immunol. 27 (2003) 889-897.
37. L.M. Pinchuk, B.L. Boyd, E.F. Kruger, I. Roditi, A. Furger, Bovine dendritic cells generated from monocytes and bone marrow progenitors regulate immunoglobulin production in peripheral blood B cells, Comp. Immunol. Microbiol. Infect. Dis 26 (2003) 233-249.
38. F.M. McCarthy, S.C. Burgess, B.H. van den Berg, M.D. Koter, G.T. Pharr, Differential detergent fractionation for non-electrophoretic eukaryote cell proteomics, J. Proteome Res 4 (2005) 316-324.
39. E. Durr, J. Yu, K.M. Krasinska, L.A. Carver, J.R. Yates, J.E. Testa, P. Oh, J.E. Schnitzer, Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture, Nat. Biotechnol. 22 (2004) 985-992.
40. D. Lopez-Ferrer, S. Martinez-Bartolome, M. Villar, M. Campillos, F. Martin-Maroto, J. Vazquez, Statistical model for large-scale peptide identification in databases from tandem mass spectra using SEQUEST, Anal. Chem. 76 (2004) 6853-6860.
41. M.J. MacCoss, C.C. Wu, J.R. Yates III, Probability-based validation of protein identifications using a modified SEQUEST algorithm, Anal. Chem. 74 (2002) 5593-5599.
42. E. Camon, D. Barrell, V. Lee, E. Dimmer, R. Apweiler, The Gene Ontology Annotation (GOA) Database - an integrated resource of GO annotations to the UniProt knowledgebase, In Silico Biol 4 (2004) 5-6.
43. F.M. McCarthy, S.M. Bridges, N. Wang, G.B. Magee, W.P. Williams, D.S. Luthe, S.C. Burgess, AgBase: a unified resource for functional analysis in agriculture, Nucleic Acids Res. 35 (2007) D599-603.
44. B. Nanduri, M.L. Lawrence, S. Vanguri, S.C. Burgess, Proteomic analysis using an unfinished bacterial genome: the effects of subminimum inhibitory concentrations of antibiotics on Mannheimia haemolytica virulence factor expression, Proteomics 5 (2005) 4852-4863.
45. S.M. Bridges, G.B. Magee, N. Wang, W.P. Williams, S.C. Burgess, B. Nanduri, ProtQuant: A tool for the label-free quantification of MudPIT proteomics data, BMC Bioinformatics 8 (Suppl 7) (2007) 24.
46. S.-R. Lee, G.T. Pharr, B.L. Boyd, L.M. Pinchuk, Bovine viral diarrhea viruses modulate Toll-like receptors, cytokines and co-modulatory molecules gene expression in bovine peripheral blood monocytes. Comp. Immunol. Microbiol. Infect. Dis. doi:10.1016/j.cimid.2007.06.006.
47. E. Harlow, D. Lane, Immunoprecipitation, Antibodies: a Laboratory Manual, Cold Spring Harbor Press, NY:Cold spring harbor, 1988, pp. 421-470.
48. M. Franchini, M. Schweizer, P. Matzenger, I. Magkouras, K.S. Sauter, J. Mirkovitch, E. Peterhans, T.W. Jungi, Evidence for dissociation of TLR mRNA expression and TLR agonist-mediated functions in bovine macrophages, Vet. Immunol. Immunopathol 110 (2006) 37-49.
49. K.L. McCance, S.E. Huether, Structure and function of the hematologic system, Pathophysiology: the Biologic Basis for Disease in Adults and Children, Elsevier, Mosby, St. Louis, MO, 2004, pp. 918-926.
50. M. Ploug, E. Ronne, N. Behrendt, A.L. Jensen, F. Blasi, K. Dano, Cellular receptor for urokinase plasmin activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol, J. Biol. Chem 266 (1991) 1926-1933.
51. T. Plesner, N. Behrendt, M. Ploug, Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR, Stem Cells 15 (1997) 3978-3408.
52. F. Mahdi, Z. Shariat-Madar, R.F. Todd, C.D. Figueroa, A.H. Schmaier, Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells, Blood 97 (2001) 2342-2350.
53. F. Mahdi, Z. Shariat-Madar, C.D. Figueroa, A.H. Schmaier, Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes, Blood 99 (2002) 3585-3596.
54. K. Bajou, A. Noel, R.D. Gerard, V. Masson, N. Brunner, C. Holst-Hanson, M. Skobe, N.E. Fusenig, P. Carmeliet, D. Collen, J.M. Foidart, Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization, Nat. Med 4 (1998) 923-928.
55. P.M. Mohan, S.K. Chintala, S. Mohanam, C.L. Gladson, E.S. Kim, Z.L. Gokaslan, S.S. Lakka, J.A. Roth, B. Fang, R. Sawaya, A.P. Kyritsis, J.S. Rao, Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth, Cancer Res 59 (1999) 3369-3373.
56. S. Huang, L. New, Z. Pan, J. Han, G.R. Nemerow, Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38? mitogen-activated protein kinase activity, J. Biol. Chem 275 (2000) 12266-122272.
57. S.S. Lakka, C.S. Gondi, N. Yanamandra, D.H. Dinh, W.C. Olivero, M. Gujrati, J.S. Rao, Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth, Cancer Res 63 (2003) 2454-2461.
58. C.S. Gondi, S.S. Lakka, N. Yanamandra, W.C. Olivero, D.H. Dinh, M. Gujarti, C.H. Tung, R. Wiessleder, J.S. Rao, Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas, Cancer Res. 64 (2004) 4069-4077.
59. G.J. Wang, M. Collinge, F. Blasi, R. Pardi, J.R. Bender, Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement, Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6296-6301.
60. T. Tauri, A.P. Mazar, D.B. Cines, Y. Takada, Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction, J. Biol. Chem 276 (2001) 3983-3990.
61. J. Bohuslav, V. Horejsi, C. Hansmann, J. Stockl, U.H. Weidle, O. Majdic, I. Bartke, W. Knapp, H. Stockinger, Urokinase plasminogen activator receptor, β2-integrins, and Src-kinases within a single receptor complex of human monocytes, J. Exp. Med. 181 (1995) 1381-1390.
62. P.E. Dekkers, T. ten Hove, A. te Velde, S.J.H. van Deventer, T. van der Poll, Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia, Infect. Immun 68 (2000) 2156-2160.
63. A.B. El-Remessy, M.A. Behzadian, G. Abou-Mohamed, T. Franklin, R.W. Caldwell, R.B. Caldwell, Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor, Am. J. Pathol 162 (2003) 1995-2004.
64. S. Omori, N. Sakai, H. Yamamoto, E. Miyamoto, N. Shimizu, N. Saito, Importance of protein kinase C targeting for the phosphorylation of its substrate, myristoilated alanine-rich C-kinase substrate, J. Biol. Chem. 275 (2000) 26449-26457.
65. M. Glaser, S. Wanaski, C.A. Buser, V. Boguslavsky, W. Rashidzada, A. Morris, M. Rebecchi, S.F. Scarlata, L.W. Runnels, G.D. Prestwich, J. Chen, A. Aderem, J. Ahn, S. McLaughlin, Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-biphosphate in lateral domains, J. Biol. Chem. 271 (1996) 2687-2613.
66. N. Kinura, N. Shimada, K. Watanabe, Isolation and characterization of a cDNA clone encoding rat nucleoside diphosphate kinase, J. Biol. Chem 26 (1990) 15744-15749.
67. A.-M. Gilles, E. Presecan, A. Vonica, I. Lascu, Nucleoside diphosphate kinase from human erythrocytes: structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme, J. Biol. Chem. 266 (1991) 8784-8789.
68. M. Hildebrandt, M.-L. Lacombe, S. Mesnildrey, M. Veron, A human NDP-kinase B specifically binds single-stranded poly-pyrimidine sequences, Nucleic Acids Res 23 (1995) 3858-3864.
69. F. Cuello, R.A. Schulze, F. Heemeyer, H.E. Meyer, S. Lutz, K.H. Jakobs, F. Niroomand, T. Wieland, Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gβ subunits, J. Biol. Chem 278 (2003) 7220-7226.
70. M. Hartsough, P. Steeg, Nm23/nucleoside diphosphate kinase in human cancers, J. Bioenerget. Biomembr 32 (2000) 301-308.
71. K.F. Tolias, A.D. Couvillon, L.C. Cantley, C.L. Carpenter, Characterization of a Rac1-and RhoGDI-associated lipid kinase signaling vomplex, Mol. Cell. Biol 18 (1998) 762-770.
72. A.L. Bishop, A. Hall, Rho GTPases and their effector proteins, Biochem. J. 348 (2000) 241-255.
73. K. Itoh, K. Yoshioka, H. Akedo, U. Masayoshi, T. Ishizaki, S. Narumiya, An essential part for Rho-associated kinase in the transcellular invasion of tumor cells, Nat. Med 5 (1999) 221-225.
74. F. Imamura, M. Mukai, M. Ayaki, H. Akedo, Y-27632, an inhibitor of Rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase, Jpn. J. Cancer Res. 91 (2000) 811-816.
75. J.E. Wilson, Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function, J. Exp. Biol. 206 (2003) 2049-2057.
76. C. Prior, P. Mamessier, H. Fukuhara, X.J. Chen, M. Wesolowski-Louvel, The hexokinase gene is required for transcriptionl regulation of the glucose transporter gene RAG1 in Kluyveromyces lactis, Mol. Cell. Biol 13 (1993) 3882-3889.
77. W.B. Frommer, W.X. Schulze, S. Lalonde, Hexokinase, Jack-of-all-trades, Science 300 (2003) 261-263.
78. Y. Nisahizuka, Protein kinase C and lipid signaling for sustained cellular responses, FASEB J. 9 (1995) 484-496.
79. G.C. Blobe, L.M. Obeid, Y.A. Hannun, Regulation of protein kinase C and role in cancer biology, Cancer Metastasis Rev 13 (1994) 411-431.
80. L. Li, K. Sampat, N. Hu, J. Zakari, S.H. Yuspa, protein kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes, J. Biol. Chem 281 (2006) 3237-3243.
81. A.M. Edelman, W.-Y. Kim, D. Higgins, E.G. Goldstein, M. Oberdoerster, W. Sigurdson, Doublecortin kinase-2, a novel doublecortin related protein kinase associated with terminal segments of axons and dendrites, J. Biol. Chem. 280 (2005) 8531-8543.
82. E.W. Dent, F.B. Gertler, Cytoskeletal dynamics and transport in growth cone motility and axon guidance, Neuron 40 (2003) 209-227.
83. M. Zhou, D.A. Horita, D.S. Waugh, A. Byrd, D.K. Morrison, Solution structure and functional analysis of the cycteine-rich C1 domain of kinase suppressor of Ras (KSR), J. Mol. Biol 315 (2002) 435-446.
84. A.C. Nguen, W.R. Burack, J.L. Stock, R. Kortum, O.V. Chaika, M. Afkarian, W.J. Muller, K.M. Murphy, D.K. Morrison, R.E. Lewis, J. McNeish, A.S. Shaw, Kinase suppressor of Ras (KRS) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo, Mol. Cell. Biol 22 (2002) 3035-3045.
85. D. Ron, C.-H. Chen, J. Calwell, L. Jamieson, E. Orr, D. Mochly-Rosen, Cloning of an intracellular receptor for protein kinase C: a homolog of the β subunit of G protein, Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 839-843.
86. J. Liliental, D.D. Chang, Rack1, a receptor for activated protein kinase C., interacts with integrin β subunit, J. Biol. Chem. 273 (1998) 2379-2383.
87. E. Croze, A. Usacheva, D. Asarnow, R.D.Minshall, H.D. Perez, O. Colamonici, Receptor for activated C-kinase (RACK-1), a WD motif-containing protein, specifically associates with the human type 1 IFN receptor, J. Immunol. 165 (2000) 5127-5132.
88. J.B. Thoden, D.J. Timson, R.J. Reece, H.M. Holden, Molecular structure of human galactokinase: implications for type II galactosemia, J. Biol. Chem 280 (2005) 9662-9670.
89. P. Cuatrecasas, S. Segal, Mammalian galactokinase: developmental and adaptive characteristics in the rat liver, J. Biol. Chem 240 (1965) 2382-2388.
90. T.A. Tedesco, W.J. Mellman, E. Soffian, Galactose-1-phosphate uridyltransferase and galactokinase activity in cultured human diploid fibroblasts and peripheral blood leukocytes. I. Analysis of transferase genotypes by the ratio of the activities of the two enzymes, J. Clin. Invest 48 (1969) 2390-2397.
91. D.B. McCormick, M.E. Gregory, E.E. Snell, Pyridoxal phosphokinases. I. Assay, distribution, purification, and properties, J. Biol. Chem. 236 (1961) 2076-2084.
92. F. Kwok, J.E. Churchich, Brain pyrodoxal kinase: purification, substrate specificities, and sensitized photodestruction of an essential histidine, J. Biol. Chem. 254 (1979) 6489-6495.
93. J.E. Leklem, Vitamin B6, in: L.J. Machin (Ed.), Handbook of Vitamins, Marcel Dekker, Inc., New York, 1991, pp. 341-392.
94. M.C. Hanna, A.J. Turner, E.F. Kirkness, Human pyridoxal kinase: cDNA cloning, expression, and modulation by ligands of the benzodiazepine receptor, J. Biol. Chem. 272 (1997) 10756-10760.
95. S. Bach, M. Knockaert, J. Reinhardt, O. Lozach, S. Schmitt, B. Baratte, M. Koken, S.P. Coburn, L. Tang, T. Jiang, D.C. Liang, H. Galons, J.F. Dierick, L.A. Pinna, F. Meggio, F. Totzke, C. Schachtele, A.S. Lerman, A. Carnero, Y. Wan, N. Gray, L. Meijer, Roscovitine targets, protein kinases and pyridoxal kinase, J.Biol. Chem. 280 (2005) 31208-31219.
96. L.M. Schang, Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication, Biochim. Biophys. Acta 1697 (2004) 197-209.
97. P.M. Brickell, The p60c-src family of protein tyrosine kinases: structure, regulation, and function, Crit. Rev. Oncog. 3 (1992) 401-446.
98. A.M. Brunati, P. James, A. Donella-Deana, B. Matoskova, K.C. Robbins, L.A. Pinna, Isolation and identification of two proto-oncogene products related to c-fgr and fyn in a tyrosine-protein-kinase fraction of rat spleen, Eur. J. Biochem 216 (1993) 323-327.
99. T. Morio, R.S. Geha, T.A. Chatila, Engagement of MHC class II molecules by staphylococcal superantigens activates src-type protein tyrosine kinases, Eur. J. Immunol 24 (1994) 651-658.
100. X.Q. Pan, C. Darby, Z.K. Indik, A.D. Schreiber, Activation of three classes of nonreceptor tyrosine kinases following Fc gamma receptor crosslinking in human monocytes, Clin. Immunol. 1 (1999) 55-64.
101. A. Donella-Deana, L. Cesaro, S. Sarno, M. Ruzzene, A.M. Brunati, O. Marin, G. Vilk, A. Doherty-Kirby, G. Lajoie, D.W. Litchfield, L.A. Pinna, Tyrosine phosphorylation of protein kinase CK2 by Src-related tyrosine kinases correlates with increased catalytic activity, Biochem. J 372 (2003) 841-849.
102. J.E. Hutchcroft, M.L. Harrison, R.L. Geahlen, Association of the 72-kDa protein tyrosine kinase PTK72 with the B cell antigen receptor, J. Biol. Chem 267 (1992) 8613-8619.
103. C.-L. Law, S.P. Sidorenko, K.A. Chandran, K.E. Draves, A.C. Chan, A. Weiss, S. Edelhoff, C.M. Disteche, E.A. Clark, Moleular cloning of human Syk: a B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex, J. Biol. Chem 269 (1994) 12310-12319.
104. S.P. Sidorenko, C.-L. Law, K.A. Chandran, E.A. Clark, Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/p56Lyn and a 120-kDa phosphoprotein, Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 359-363.
105. S. Atwell, J.M. Adams, J. Badger, M.D. Buchanan, I.K. Feil, K.J. Froning, X. Gao, J. Hendle, K. Keegan, B.C. Leon, H.J. Muller-Dieckmann, V.L. Nienaber, B.W. Noland, K. Post, K.R. Rajashankar, A. Ramos, M. Russell, S.K. Burley, S.G. Buchanan, A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase, J. Biol. Chem. 279 (2004) 55827-55832.
106. C. Darby, R.L. Geahlen, A.D. Schreiber, Stimulation of macrophage Fc gamma RIIIA activates the receptor-associated protein tyrosine kinase Syk and induces phosphorylation of multiple proteins including p95Vav and p62/GAP-associated protein, J. Immunol 152 (1994) 5429-5437.
107. K. Tani, H. Fujii, S. Nagata, S. Miwa, Human liver type pyruvate kinase: complete amino acid sequence and the expression in mammalian cells, Proc. Natl. Acad Sci. U. S .A. 85 (1988) 1792-1794.
108. A. Stetak, R. Veress, J. Ovadi, P. Csermley, G. Keri, A. Ullrich, Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death, Cancer Res. 67 (2007) 1602-1608.
109. M. Qi, E. Elion, MAP kinase pathways, J. Cell Sci. 118 (2005) 3569-3572.
110. M. Takekawa, H. Saito, A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK, Cell 95 (1998) 521-530.
111. L. Chang, M. Karin, Mammalian MAP kinase signalling cascades, Nature 410 (2001) 37-40.
112. K. Takeda, A. Matsuzawa, H. Nishitoh, H. Ichijo, Roles of MAPKKK ASK1 in stress-induced cell death, Cell Struct. Funct 28 (2003) 23-29.
113. H. Nagakami, S. Kiegerl, H. Hirt, OMTK1, a novel MAPKKK, channels oxidative stress signaling through direct MAPK interaction, J. Biol. Chem. 279 (2004) 26959-26966.
114. B. Houssa, J. de Widt, O. Kranenburg, W.H. Moolenaar, W.J. van Bitterswijk, Diacylglycerol kinase θ binds to and is negatively regulated by active RhoA, J. Biol. Chem 274 (1999) 6820-6822.
115. N.J. Horwood, T. Mahon, J.P. McDaid, J. Campbell, H. Mano, F.M. Brennan, D. Webster, B.M.J. Foxwell, Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor ? production, J. Exp. Med. 197 (2003) 1603-1609.
116. K.E. Neet, R.P. Keenan, P.S. Tippett, Observation of a kinetic slow transition in monomeric glucokinase, Biochemistry 29 (1990) 770-779.
117. R.J. Kraaijenhagen, M.C. van der Heijden, M. Rijksen, G.C. de Gast, G.E. Staal, Hexokinase, phosphofructokinase and pyruvate kinase isoenzymes in lymphocyte subpopulations, Clin. Chim. Acta 140 (1984) 65-76.
118. A. Minchenko, I. Leshchinsky, I. Opentanova, N. Sang, V. Srinivas, V. Armstead, J. Caro, Hypoxia-inducible factor 1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-3 (PFKFB3) gene, J. Biol. Chem 277 (2002) 6183-6187.